Portolan Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.84M | Sell |
30,763
-14,305
| -32% | -$4.11M | 0.55% | 58 |
|
2025
Q1 | $13.9M | Buy |
45,068
+30,819
| +216% | +$9.5M | 1.06% | 34 |
|
2024
Q4 | $5.03M | Sell |
14,249
-16,257
| -53% | -$5.74M | 0.34% | 91 |
|
2024
Q3 | $10.9M | Sell |
30,506
-24,339
| -44% | -$8.72M | 0.79% | 43 |
|
2024
Q2 | $17.5M | Sell |
54,845
-56,077
| -51% | -$17.9M | 1.44% | 17 |
|
2024
Q1 | $25.5M | Buy |
110,922
+19,114
| +21% | +$4.39M | 1.94% | 12 |
|
2023
Q4 | $20.2M | Buy |
91,808
+10,760
| +13% | +$2.37M | 1.77% | 11 |
|
2023
Q3 | $18.3M | Buy |
81,048
+47,582
| +142% | +$10.7M | 1.71% | 12 |
|
2023
Q2 | $7.39M | Sell |
33,466
-44,282
| -57% | -$9.78M | 0.65% | 43 |
|
2023
Q1 | $17.4M | Sell |
77,748
-1,069
| -1% | -$239K | 1.66% | 13 |
|
2022
Q4 | $21.9M | Sell |
78,817
-2,473
| -3% | -$688K | 2.17% | 6 |
|
2022
Q3 | $17M | Sell |
81,290
-3,554
| -4% | -$744K | 1.8% | 13 |
|
2022
Q2 | $20M | Buy |
+84,844
| New | +$20M | 2.01% | 9 |
|
2020
Q3 | – | Sell |
-75,039
| Closed | -$9.08M | – | 155 |
|
2020
Q2 | $9.08M | Sell |
75,039
-39,738
| -35% | -$4.81M | 1.04% | 33 |
|
2020
Q1 | $10.9M | Buy |
+114,777
| New | +$10.9M | 1.63% | 17 |
|
2018
Q1 | – | Sell |
-34,227
| Closed | -$5.06M | – | 113 |
|
2017
Q4 | $5.06M | Sell |
34,227
-11,962
| -26% | -$1.77M | 0.55% | 67 |
|
2017
Q3 | $5.41M | Buy |
+46,189
| New | +$5.41M | 0.65% | 61 |
|
2017
Q2 | – | Sell |
-33,469
| Closed | -$4.53M | – | 136 |
|
2017
Q1 | $4.53M | Sell |
33,469
-47,447
| -59% | -$6.42M | 0.59% | 66 |
|
2016
Q4 | $11.6M | Buy |
80,916
+34,635
| +75% | +$4.97M | 1.56% | 15 |
|
2016
Q3 | $5.47M | Sell |
46,281
-70,320
| -60% | -$8.3M | 0.75% | 54 |
|
2016
Q2 | $12.4M | Buy |
116,601
+12,180
| +12% | +$1.29M | 1.78% | 13 |
|
2016
Q1 | $11.6M | Buy |
104,421
+75,466
| +261% | +$8.41M | 1.56% | 16 |
|
2015
Q4 | $4.54M | Buy |
+28,955
| New | +$4.54M | 0.57% | 70 |
|